Subscribe to our Newsletters !!
The safety and quality of produced medicines is ex
Automation of sample preparation has become the mo
A new COVID-19 variant, BA.3.2, informally called
Alembic Pharmaceutica
Can gene editing be used as a life-saving treatmen
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to a fresh and forward-look
Gene and cell treatment firm Oxford Biomedica plc said on Monday it had named French pharmaceutical industry veteran Roch Doliveux as its non-official administrator, as it eyes a possibly significant job in delivering coronavirus antibody.
Doliveux, who right now fills in as a non-official chief at Stryker Corp, will take up his job at Oxford from June 24, the organization said.
A week ago, AstraZeneca reported an association with Oxford to make its test COVID-19 immunization as the drugmaker hopes to support its assembling ability to deliver one billion dosages.
